1st September 2026, Tuesday

TechPharus

Latest Posts

HealthTech News

  • After TAVI, anticoagulants outperform antiplatelet agents at preventing clots
    on September 1, 2026 at 2:40 am

    After transcatheter aortic valve implantation (TAVI), anticoagulation reduced imaging signs of clot formation on the new valve compared with antiplatelet therapy, without compromising safety. This was the main finding of the ACASA-TAVI trial presented in a Hot Line session at ESC Congress 2026 and published simultaneously in JAMA.

  • Night owls experience more mental health issues than early birds and take longer to recover from work
    on September 1, 2026 at 2:20 am

    Balancing work and personal life is more challenging for evening types, or “night owls,” than for morning types, or “early birds.” Evening types have a harder time recovering from work and are more likely to have mental health symptoms and diagnoses than morning types. Evening types also have less healthy lifestyles, although this does not explain the challenges with work-life balance or mental health issues that are emphasized among evening types compared with other circadian types.

  • Public confidence in one’s own health care provider remains high
    on September 1, 2026 at 2:00 am

    Americans’ confidence in their own health care providers remains high, according to a longitudinal, nationally representative survey conducted by the Annenberg Public Policy Center (APPC) of the University of Pennsylvania from April 2021 to August 2026.

  • Potential treatment could prevent millions of annual heart failures and deaths in severe heart attack patients
    on September 1, 2026 at 1:40 am

    A clinical trial in which cardiac patients received intravenous dexrazoxane before, during and after their blocked coronary artery was reopened showed a reduction in bleeding within the heart muscle, intramyocardial hemorrhage (IMH), in adults with a severe heart attack called ST-segment elevation myocardial infarction (STEMI). This trial was performed by clinical investigators from the Cardiovascular Imaging Research Center (CIRC) at Indiana University School of Medicine.

  • High fertility costs push Americans abroad for IVF treatment
    on September 1, 2026 at 1:20 am

    A growing number of Americans are looking abroad, particularly to Greece and Spain, to escape the high cost of fertility treatments in the U.S., where such procedures are often not covered by insurance. The treatments include in vitro fertilization, which involves ovulation stimulation, retrieving eggs, fertilizing them in a lab and transferring the embryos into the uterus. Other less intensive medical therapies also address infertility.